首页> 外国专利> ANALOGUES OF CORTISTATIN, THEIR SYNTHESIS AND APPLICATIONS

ANALOGUES OF CORTISTATIN, THEIR SYNTHESIS AND APPLICATIONS

机译:皮质抑素的类似物及其合成与应用

摘要

This document presents the compounds of formulas (A), (B), (C), (D) and (E), their pharmaceutically acceptable salts, quaternary amine salts and N-oxides, as well as their pharmaceutical compositions. Considered compounds of formulas (A ), (B), (C), (D), and (E) are useful as therapeutic agents for treating a wide range of conditions, for example, including, but not limited to, conditions associated with angiogenesis and the activity of CDK8 and / or CDK19 kinases. In addition, methods are provided for inhibiting the activity of CDK8 and / or CDK19 kinases, methods for modulating the β-catenin pathway, methods for modulating STAT1 activity, methods for modulating the TGFβ / BMP pathway, methods for modulating HIF-1 alpha activity in a cell, and methods for increasing BIM expression to induce apoptosis using a compound of formulas (A), (B), (C), (D) or (E). In addition, point mutants CDK8 and CDK19 and methods for their use are presented.
机译:该文献提供了式(A),(B),(C),(D)和(E)的化合物,其药学上可接受的盐,季胺盐和N-氧化物,以及它们的药物组合物。认为的式(A),(B),(C),(D)和(E)化合物可用作治疗多种病症的治疗剂,例如包括但不限于与以下病症有关的病症:血管生成和CDK8和/或CDK19激酶的活性。另外,提供了抑制CDK8和/或CDK19激酶活性的方法,调节β-连环蛋白途径的方法,调节STAT1活性的方法,调节TGFβ/ BMP途径的方法,调节HIF-1α活性的方法。以及使用式(A),(B),(C),(D)或(E)的化合物增加BIM表达以诱导凋亡的方法。此外,还介绍了点突变体CDK8和CDK19及其使用方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号